Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Putra Rajawali Kencana Tbk. (PURA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Putra Rajawali Kencana Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Putra Rajawali Kencana Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume), while Putra Rajawali Kencana Tbk. trades at Rp33 (market cap 207.96B, 3.72M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.1× Putra Rajawali Kencana Tbk.'s market cap, and Putra Rajawali Kencana Tbk. is more actively traded (3.72M versus 848.2K). Which is the better fit depends on your goals.

LABSPURA
Market Cap
651.75B207.96B
Volume
848.2K3.72M
Lot
8.48K37.21K
Turnover
140.51M121.48M
Average Price
165.6632.65
Value
140.51M121.48M
Indicative Equilibrium Price
16833
Indicative Equilibrium Volume
504.74K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
PURA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Putra Rajawali Kencana Tbk.

PT Putra Rajawali Kencana Tbk (the Company) was established based on notary deed No. 05 dated April 17, 2012 of Juanita Sari Dewi, SH., notary in Surabaya.

Read more on PURA